"10.1371_journal.pone.0083232","plos one","2013-12-13T00:00:00Z","Klaus Mross; Heike Richly; Richard Fischer; Dirk Scharr; Martin Büchert; Angelika Stern; Hendrik Gille; Laurent P Audoly; Max E Scheulen","Klinik für Tumorbiologie, Albert-Ludwigs Universität, Freiburg, Germany; Department of Medical Oncology, West German Cancer Center, University Hospital, University Duisburg-Essen, Essen, Germany; Department of Gastroenterology, University Medical Center, Freiburg, German; Magnetic Resonance Development and Application Center, University Medical Center, Freiburg, Germany; Stern Consult, Basel, Switzerland; Pieris AG, Freising, Germany","Conceived and designed the experiments: KM AS LPA MB HG. Analyzed the data: KM HR MES MB HG LPA. Contributed reagents/materials/analysis tools: KM DS HR RF MES. Wrote the manuscript: KM HR RF DS MB AS HG LPA MES.","This study was sponsored by Pieris AG, the employer of HG and LPA. AS is affiliated to Stern Consult. There is a pending patent (PCT/EP2012/072406) relating to this study: \"Novel uses of VEGF antagonists\", inventors HG and LPA. KM and MES have received a travel grant from Pieris AG, and AS and MES have consulted for Pieris AG. There are no further patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.","2013","12","Klaus Mross","KM",9,TRUE,5,NA,6,9,TRUE,TRUE,FALSE,0,NA,FALSE
